ArticleRheumatology (Oxford, England)2021

Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register.

Katie Bechman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.